45: Rescue Thrombolysis with Low-Dose Alteplase for ECMO Canuula Thrombosis Despite Adequate Anticoagulation: A Case Report

Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is an established rescue therapy for patients with severe, reversible respiratory failure. However, thrombotic complications remain a significant concern despite appropriate anticoagulation and can jeopardize circuit function and patient safety. Management options range from anticoagulation adjustment to thrombolytic therapy or circuit exchange, depending on severity and clinical context. Case Presentation: A 41-year-old male with severe ARDS secondary to H1N1 infection and septic shock was initiated on VV-ECMO after failure of conventional therapy and multiple proning sessions. Despite adequate anticoagulation with unfractionated heparin (target ACT 180–200 seconds), he developed rising drainage pressures and reduced ECMO flows. Transesophageal echocardiography revealed large mobile thrombi in the inferior vena cava and superior vena cava cannula tips. The patient was promptly managed with circuit change and pharmacologic thrombolysis was initiated with intravenous alteplase 25 mg over 24 hours, along with heparin infusion. Thrombolysis resulted in partial resolution of the thrombus and improved ECMO flow. The course was complicated by transient hematuria, which resolved upon temporary cessation of alteplase. Systemic anticoagulation was continued thereafter, maintaining circuit stability. Serial echocardiography showed gradual reduction in thrombus size and eventual resolution. Discussion: Cannula-related thrombosis on VV-ECMO can occur despite therapeutic anticoagulation. In select cases, low-dose systemic alteplase can be an effective management strategy when closely monitored for bleeding complications. Conclusion: Systemic thrombolysis with alteplase represents a viable rescue strategy for ECMO cannula thrombosis, offering restoration of circuit function while avoiding surgical intervention, provided it is administered under vigilant multidisciplinary supervision. Keywords: VV-ECMO, Cannula thrombosis, Alteplase, Thrombolysis, ARDS, Extracorporeal life support

Authors

Institutions

Publication Details

Journal
ASAIO Journal
Published
2026-02-01
DOI
https://doi.org/10.1097/01.mat.0001180864.08373.66
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

45: Rescue Thrombolysis with Low-Dose Alteplase for ECMO Canuula Thrombosis Despite Adequate Anticoagulation: A Case Report

Munish Chauhan, Sanjoli Makkar, Sandeep Dewan
ASAIO Journal
Mechanical Circulatory Support Devices
article

45: Rescue Thrombolysis with Low-Dose Alteplase for ECMO Canuula Thrombosis Despite Adequate Anticoagulation: A Case Report

Munish Chauhan, Sanjoli Makkar, Sandeep Dewan
article en

Abstract

Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is an established rescue therapy for patients with severe, reversible respiratory failure. However, thrombotic complications remain a significant concern despite appropriate anticoagulation and can jeopardize circuit function and patient safety. Management options range from anticoagulation adjustment to thrombolytic therapy or circuit exchange, depending on severity and clinical context. Case Presentation: A 41-year-old male with severe ARDS secondary to H1N1 infection and septic shock was initiated on VV-ECMO after failure of conventional therapy and multiple proning sessions. Despite adequate anticoagulation with unfractionated heparin (target ACT 180–200 seconds), he developed rising drainage pressures and reduced ECMO flows. Transesophageal echocardiography revealed large mobile thrombi in the inferior vena cava and superior vena cava cannula tips. The patient was promptly managed with circuit change and pharmacologic thrombolysis was initiated with intravenous alteplase 25 mg over 24 hours, along with heparin infusion. Thrombolysis resulted in partial resolution of the thrombus and improved ECMO flow. The course was complicated by transient hematuria, which resolved upon temporary cessation of alteplase. Systemic anticoagulation was continued thereafter, maintaining circuit stability. Serial echocardiography showed gradual reduction in thrombus size and eventual resolution. Discussion: Cannula-related thrombosis on VV-ECMO can occur despite therapeutic anticoagulation. In select cases, low-dose systemic alteplase can be an effective management strategy when closely monitored for bleeding complications. Conclusion: Systemic thrombolysis with alteplase represents a viable rescue strategy for ECMO cannula thrombosis, offering restoration of circuit function while avoiding surgical intervention, provided it is administered under vigilant multidisciplinary supervision. Keywords: VV-ECMO, Cannula thrombosis, Alteplase, Thrombolysis, ARDS, Extracorporeal life support

ASAIO JournalVol. 72(Supplement 1)
Fortis Memorial Research Institute (IN)
Openalex Percentile: Top 67%
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.